Literature DB >> 10394006

Minimum inhibitory and minimal lethal concentration against Chlamydia trachomatis dependent on the time of addition and the duration of the presence of antibiotics.

T Notomi1, Y Ikeda, A Nagayama.   

Abstract

The purpose of this study was to investigate the properties of several antimicrobial agents found to be effective against Chlamydia trachomatis and to verify the eradication therapy schedule. The in vitro activities of two quinolones (sparfloxacin, ofloxacin), of three macrolides (azithromycin, erythromycin, clarithromycin) and of a tetracycline (doxycycline) against C. trachomatis were evaluated by several methods for the determination of the minimum inhibitory concentration (MIC) and minimal lethal concentration (MLC). MLC of azithromycin was only 2 times higher than that of MIC. On the other hand, MLCs of other antibiotics were 4-16 times higher than their respective MICs. When all antimicrobial agents were added to the infected culture at different times, we found that the quinolones even at a concentration of 64 microg/ml could not inhibit the formation of inclusion if they were added after 20 h from the start of infection. The corresponding period for macrolides and doxycycline was 24 h. When the antibiotics were removed at 8 h after the start of the infection, all antibiotics except azithromycin and clarithromycin were needed at a concentration much higher than their MLCs to inhibit the formation of inclusion. We consider macrolides, especially azithromycin, to be an excellent anti-C. trachomatis drug because of its lower MICs and MLCs values which were also closer together.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10394006     DOI: 10.1159/000007192

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  5 in total

1.  In vitro effects of spectinomycin and ceftriaxone alone or in combination with other antibiotics against Chlamydia trachomatis.

Authors:  Shuxian Shang; Longqing Xia; Mingying Zhong; Jinping Zhang; Jianbin Zhao; Xiangdong Gong; David Mabey; Qianqiu Wang
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

2.  Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro.

Authors:  U Dreses-Werringloer; I Padubrin; H Zeidler; L Köhler
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

3.  Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp.

Authors:  R J Suchland; W M Geisler; Walter E Stamm
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

4.  Direct assessment of possible mutations in the 23S rRNA gene encoding macrolide resistance in Chlamydia trachomatis.

Authors:  J M van Niekerk; I H M van Loo; M Lucchesi; S A Morré; C J P A Hoebe; N H T M Dukers-Muijrers; P F G Wolffs
Journal:  PLoS One       Date:  2022-05-10       Impact factor: 3.240

5.  Time-to-Death approach in revealing Chronicity and Severity of COVID-19 across the World.

Authors:  Vivek Verma; Ramesh K Vishwakarma; Anita Verma; Dilip C Nath; Hafiz T A Khan
Journal:  PLoS One       Date:  2020-05-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.